Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smartphone app could help wet AMD patients space out eye injections

NCT ID NCT07340372

Not yet recruiting Disease control Sponsor: Association for Innovation and Biomedical Research on Light and Image Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a home monitoring app can help people with wet age-related macular degeneration (eAMD) safely extend the time between Aflibercept injections. About 80 adults already receiving this treatment will use the app and have regular eye exams over one to two years. The goal is to see if vision stays stable with longer treatment intervals and to measure patient satisfaction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Aflibercept 8 mg injection
What this could lead to
If successful, this could show that home monitoring allows patients with wet AMD to safely extend time between eye injections, reducing clinic visits while maintaining vision.
What could go wrong
This is an observational study with only 80 participants, so results may not apply to everyone. The home monitoring app's accuracy and patient adherence are unproven in this setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXUDATIVE AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

wet macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EXUDATIVE AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Locations

  • Espaço Médico de Coimbra, Lda.

    Coimbra, Portugal

  • Instituto Português de Microcirurgia Ocular, Lda.

    Lisbon, Portugal

  • Unidade Local de Saúde Loures-Odivelas

    Loures, Portugal

  • Unidade Local de Saúde de Coimbra, E.P.E.

    Coimbra, Portugal

  • Unidade Local de Saúde de Leiria, E.P.E.

    Leiria, Portugal

  • Unidade Local de Saúde de Lisboa Ocidental - Hospital de Egas Moniz

    Lisbon, Portugal

  • Unidade Local de Saúde de Santo António, E.P.E.

    Porto, Portugal

  • Unidade Local de Saúde de São João, E.P.E.

    Porto, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.